Market Cap 119.87B
Revenue (ttm) 48.19B
Net Income (ttm) 7.05B
EPS (ttm) N/A
PE Ratio 9.60
Forward PE 9.41
Profit Margin 14.64%
Debt to Equity Ratio 2.44
Volume 6,822,800
Avg Vol 12,036,166
Day's Range N/A - N/A
Shares Out 2.04B
Stochastic %K 46%
Beta 0.27
Analysts Sell
Price Target $62.81

Company Profile

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Opdivo for various anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumorsr; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of patients with unres...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 609 252 4621
Website: www.bms.com
Address:
Route 206 & Province Line Road, Princeton, United States
LiveCommander
LiveCommander Apr. 26 at 11:55 PM
04/27 Watchlist — clean inside bar setups, waiting for expansion. Not guessing direction here — just letting price choose. $BMY 🩺 Above 59.7 → I’ll take calls for continuation Below 57.8 → flips bearish, look for puts $LVS 🎰 Holding tight range — break 53.9 = momentum long Lose 50 → downside opens fast $MO 🚬 Slow mover but clean levels 67.4 breaks = grind higher 65.3 fails = short trigger $TSLA 🏎️ Compression is real here Above 386 = squeeze potential Below 368 = fade setup 📊 Inside bars = volatility compression → expansion follows I don’t predict, I react to breaks + hold 👉 Which one are you watching at the open?👉If this is helpful to you, tap @LiveCommander
0 · Reply
DragonAlgo
DragonAlgo Apr. 26 at 8:10 PM
🐉 $BMY CALL — DragonAlgo® Signal Contract: BMY CALL Expiry: 2026-05-01 | Strike: $59.00 | Type: CALL Option Plan (premium): Entry: $1.38 Stop: $0.99 TP1: $1.79 TP2: $2.34 TP3: $3.30 Volatility regime is active. 🔗 https://dragonalgo.com
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 26 at 3:26 PM
$CDXS $RNA $BMY https://acsgcipr.org/sustainable-manufacturing-of-bms-986278-leveraging-an-ered-kred-biocatalytic-cascade/
1 · Reply
Fingerlickengood
Fingerlickengood Apr. 25 at 1:09 PM
$CDXS $NVS $BMY Of course she is excited! “We are excited about this relationship as it represents an important entry point into what could become a high-volume opportunity,” said Alison Moore, President and Chief Executive Officer of Codexis. “Engagements like this illustrate our path to growth as we continue to expand partnerships and position the platform for potential commercial-scale applications.” https://www.biopharmaboardroom.com/news/56/4440/codexis-inc-advances-rna-manufacturing-with-50g-sirna-production-agreement-for-cardiovascular-program.html
1 · Reply
Fingerlickengood
Fingerlickengood Apr. 25 at 1:06 PM
$CDXS $NVS $BMY https://www.prnewswire.com/news-releases/atrium-therapeutics-earns-15-million-milestone-payment-from-bristol-myers-squibb-under-global-cardiovascular-collaboration-302751102.html
0 · Reply
FRthDKSD
FRthDKSD Apr. 24 at 6:02 PM
$BMY what a dud lol
0 · Reply
MF__DOOM
MF__DOOM Apr. 24 at 5:38 PM
$HIMS let’s see going into next week careful but could work $LLY $NVO $BMY $XBI
0 · Reply
DragonAlgo
DragonAlgo Apr. 24 at 5:35 PM
🐉 $BMY PUT — DragonAlgo® Signal Contract: BMY PUT Expiry: 2026-04-24 | Strike: $60.00 | Type: PUT Option Plan (premium): Entry: $1.32 Stop: $0.95 TP1: $1.72 TP2: $2.25 TP3: $3.18 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
taxplanr
taxplanr Apr. 24 at 1:55 PM
PSA's dropping with Ivermectin and Fenbendazole $BNTX $MRNA $MRK $BMY https://makisw.substack.com/p/ivermectin-and-fenbendazole-testimonial-fbe?utm_source=post-email-title&publication_id=1385328&post_id=195292908&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
focafoca99
focafoca99 Apr. 24 at 1:53 PM
$BMY opens a new direct-to-patient channel for Eliquis https://www.rapidticker.com/news/bmy-bristol-myers-squibb-and-pfizer-b32e9e
0 · Reply
Latest News on BMY
Bristol Myers Squibb Announces Dividend

Mar 2, 2026, 4:16 PM EST - 7 weeks ago

Bristol Myers Squibb Announces Dividend


Bristol Myers Flags Data-Rich 2026 After Solid Quarter

Feb 5, 2026, 10:07 AM EST - 2 months ago

Bristol Myers Flags Data-Rich 2026 After Solid Quarter


Bristol-Myers Squibb Company Earnings Call Transcript: Q4 2025

Feb 5, 2026, 8:00 AM EST - 2 months ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q4 2025


Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth

Feb 5, 2026, 7:09 AM EST - 2 months ago

Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth


Final Trade: BMY, IGV, SOXX, GEN, AMZN

Jan 21, 2026, 6:17 PM EST - 3 months ago

Final Trade: BMY, IGV, SOXX, GEN, AMZN

AMZN SOXX IGV


2 Top Blue-Chip Stocks to Buy and Hold in 2026

Jan 20, 2026, 11:00 AM EST - 3 months ago

2 Top Blue-Chip Stocks to Buy and Hold in 2026

MSFT


3 Stock Picks Where Technical Indicators Still Say Buy

Jan 15, 2026, 4:02 AM EST - 3 months ago

3 Stock Picks Where Technical Indicators Still Say Buy

BURL ITRN


Bristol-Myers Squibb Company Transcript: Status Update

Dec 11, 2025, 9:00 AM EST - 4 months ago

Bristol-Myers Squibb Company Transcript: Status Update


Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2025

Oct 30, 2025, 8:00 AM EDT - 6 months ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2025


Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2025

Jul 31, 2025, 8:00 AM EDT - 9 months ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2025


Bristol-Myers Squibb Company Transcript: AGM 2025

May 6, 2025, 10:00 AM EDT - 1 year ago

Bristol-Myers Squibb Company Transcript: AGM 2025


Bristol-Myers Squibb Company Transcript: AGM 2024

May 7, 2024, 10:00 AM EDT - 2 years ago

Bristol-Myers Squibb Company Transcript: AGM 2024


Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2024

Apr 25, 2024, 8:00 AM EDT - 2 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2024


Bristol-Myers Squibb Company Transcript: M&A Announcement

Dec 22, 2023, 8:00 AM EST - 2 years ago

Bristol-Myers Squibb Company Transcript: M&A Announcement


Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2023

Oct 26, 2023, 8:00 AM EDT - 2 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2023


Bristol-Myers Squibb Company Transcript: R&D Day 2023

Sep 14, 2023, 9:00 AM EDT - 2 years ago

Bristol-Myers Squibb Company Transcript: R&D Day 2023


Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2023

Jul 27, 2023, 8:00 AM EDT - 2 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2023


Bristol-Myers Squibb Company Transcript: ASCO 2023

Jun 1, 2023, 8:00 PM EDT - 3 years ago

Bristol-Myers Squibb Company Transcript: ASCO 2023


Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2023

Apr 27, 2023, 8:00 AM EDT - 3 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2023


Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2022

Oct 26, 2022, 8:00 AM EDT - 3 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2022


Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2022

Jul 26, 2022, 9:29 PM EDT - 4 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2022


Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2022

Apr 29, 2022, 12:50 PM EDT - 4 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2022


Bristol-Myers Squibb Company Transcript: Investor Day 2021

Nov 16, 2021, 5:28 AM EST - 4 years ago

Bristol-Myers Squibb Company Transcript: Investor Day 2021


Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2021

Oct 26, 2021, 8:00 PM EDT - 4 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2021


Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2021

Jul 28, 2021, 7:30 AM EDT - 5 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2021


Bristol-Myers Squibb Company Transcript: Status Update

Jun 8, 2021, 6:34 AM EDT - 5 years ago

Bristol-Myers Squibb Company Transcript: Status Update


Bristol-Myers Squibb Company Transcript: AGM 2021

May 4, 2021, 6:44 AM EDT - 5 years ago

Bristol-Myers Squibb Company Transcript: AGM 2021


Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2021

Apr 29, 2021, 7:31 AM EDT - 5 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q1 2021


Bristol-Myers Squibb Company Transcript: Status Update

Apr 22, 2021, 7:26 PM EDT - 5 years ago

Bristol-Myers Squibb Company Transcript: Status Update


Bristol-Myers Squibb Company Transcript: Investor Update

Oct 11, 2020, 8:18 PM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: Investor Update


Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2020

Oct 11, 2020, 8:12 PM EDT - 6 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2020


Bristol-Myers Squibb Company Transcript: M&A Announcement

Oct 5, 2020, 8:00 AM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: M&A Announcement


Bristol-Myers Squibb Company Transcript: Investor Update

Sep 20, 2020, 8:36 PM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: Investor Update


Bristol-Myers Squibb Company Transcript: Investor Update

Jun 26, 2020, 10:00 AM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: Investor Update


Bristol-Myers Squibb Company Transcript: Investor Update

Jun 25, 2020, 10:00 AM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: Investor Update


Bristol-Myers Squibb Company Transcript: Investor Update

Jun 22, 2020, 12:00 PM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: Investor Update


Bristol-Myers Squibb Company Transcript: Investor Update

May 13, 2020, 10:00 AM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: Investor Update


Bristol-Myers Squibb Company Transcript: AGM 2020

May 4, 2020, 9:38 PM EDT - 6 years ago

Bristol-Myers Squibb Company Transcript: AGM 2020


Bristol-Myers Squibb Company Transcript: Status Update

Dec 8, 2019, 9:51 PM EST - 6 years ago

Bristol-Myers Squibb Company Transcript: Status Update


Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2019

Oct 30, 2019, 10:54 PM EDT - 7 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2019


Bristol-Myers Squibb Company Transcript: Status Update

Sep 27, 2019, 10:04 PM EDT - 7 years ago

Bristol-Myers Squibb Company Transcript: Status Update


Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2019

Jul 24, 2019, 10:10 PM EDT - 7 years ago

Bristol-Myers Squibb Company Earnings Call Transcript: Q2 2019


LiveCommander
LiveCommander Apr. 26 at 11:55 PM
04/27 Watchlist — clean inside bar setups, waiting for expansion. Not guessing direction here — just letting price choose. $BMY 🩺 Above 59.7 → I’ll take calls for continuation Below 57.8 → flips bearish, look for puts $LVS 🎰 Holding tight range — break 53.9 = momentum long Lose 50 → downside opens fast $MO 🚬 Slow mover but clean levels 67.4 breaks = grind higher 65.3 fails = short trigger $TSLA 🏎️ Compression is real here Above 386 = squeeze potential Below 368 = fade setup 📊 Inside bars = volatility compression → expansion follows I don’t predict, I react to breaks + hold 👉 Which one are you watching at the open?👉If this is helpful to you, tap @LiveCommander
0 · Reply
DragonAlgo
DragonAlgo Apr. 26 at 8:10 PM
🐉 $BMY CALL — DragonAlgo® Signal Contract: BMY CALL Expiry: 2026-05-01 | Strike: $59.00 | Type: CALL Option Plan (premium): Entry: $1.38 Stop: $0.99 TP1: $1.79 TP2: $2.34 TP3: $3.30 Volatility regime is active. 🔗 https://dragonalgo.com
0 · Reply
Fingerlickengood
Fingerlickengood Apr. 26 at 3:26 PM
$CDXS $RNA $BMY https://acsgcipr.org/sustainable-manufacturing-of-bms-986278-leveraging-an-ered-kred-biocatalytic-cascade/
1 · Reply
Fingerlickengood
Fingerlickengood Apr. 25 at 1:09 PM
$CDXS $NVS $BMY Of course she is excited! “We are excited about this relationship as it represents an important entry point into what could become a high-volume opportunity,” said Alison Moore, President and Chief Executive Officer of Codexis. “Engagements like this illustrate our path to growth as we continue to expand partnerships and position the platform for potential commercial-scale applications.” https://www.biopharmaboardroom.com/news/56/4440/codexis-inc-advances-rna-manufacturing-with-50g-sirna-production-agreement-for-cardiovascular-program.html
1 · Reply
Fingerlickengood
Fingerlickengood Apr. 25 at 1:06 PM
$CDXS $NVS $BMY https://www.prnewswire.com/news-releases/atrium-therapeutics-earns-15-million-milestone-payment-from-bristol-myers-squibb-under-global-cardiovascular-collaboration-302751102.html
0 · Reply
FRthDKSD
FRthDKSD Apr. 24 at 6:02 PM
$BMY what a dud lol
0 · Reply
MF__DOOM
MF__DOOM Apr. 24 at 5:38 PM
$HIMS let’s see going into next week careful but could work $LLY $NVO $BMY $XBI
0 · Reply
DragonAlgo
DragonAlgo Apr. 24 at 5:35 PM
🐉 $BMY PUT — DragonAlgo® Signal Contract: BMY PUT Expiry: 2026-04-24 | Strike: $60.00 | Type: PUT Option Plan (premium): Entry: $1.32 Stop: $0.95 TP1: $1.72 TP2: $2.25 TP3: $3.18 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
taxplanr
taxplanr Apr. 24 at 1:55 PM
PSA's dropping with Ivermectin and Fenbendazole $BNTX $MRNA $MRK $BMY https://makisw.substack.com/p/ivermectin-and-fenbendazole-testimonial-fbe?utm_source=post-email-title&publication_id=1385328&post_id=195292908&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
focafoca99
focafoca99 Apr. 24 at 1:53 PM
$BMY opens a new direct-to-patient channel for Eliquis https://www.rapidticker.com/news/bmy-bristol-myers-squibb-and-pfizer-b32e9e
0 · Reply
DragonAlgo
DragonAlgo Apr. 23 at 10:51 PM
🐉 $BMY CALL — DragonAlgo® Signal Contract: BMY CALL Expiry: 2026-05-01 | Strike: $59.00 | Type: CALL Option Plan (premium): Entry: $1.51 Stop: $1.09 TP1: $1.96 TP2: $2.57 TP3: $3.62 System-defined risk profile. 🔗 https://dragonalgo.com
0 · Reply
OrvalCrossfield
OrvalCrossfield Apr. 23 at 6:20 PM
$BMY lagging, needs buyers to defend current levels
0 · Reply
Jami_JO
Jami_JO Apr. 23 at 11:40 AM
$BMY slow but okay
0 · Reply
DragonAlgo
DragonAlgo Apr. 23 at 4:34 AM
🐉 $BMY CALL — DragonAlgo® Signal Contract: BMY CALL Expiry: 2026-04-24 | Strike: $59.00 | Type: CALL Option Plan (premium): Entry: $0.44 Stop: $0.32 TP1: $0.57 TP2: $0.75 TP3: $1.06 🔗 https://dragonalgo.com
0 · Reply
taxplanr
taxplanr Apr. 23 at 2:17 AM
$BNTX $MRNA $BMY $MRK can't compete with natural bacteria https://scitechdaily.com/naturally-occurring-bacteria-completely-eradicate-tumors-in-mice-with-a-single-dose/
0 · Reply
taxplanr
taxplanr Apr. 23 at 2:07 AM
Newly discovered bacterium eradicated tumors $BNTX $MRNA $MRK $BMY https://www.instagram.com/reel/DXZaq75DR__/?igsh=dWR1ZGt5cmx2YTFu
0 · Reply
taxplanr
taxplanr Apr. 23 at 12:56 AM
Ivermectin and Fenbendazole cancel Cancer radiation and surgery $BNTX $MRNA $MRK $BMY https://makisw.substack.com/p/ivermectin-and-fenbendazole-and-iv?utm_source=post-email-title&publication_id=1385328&post_id=195184373&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
1 · Reply
Khaiman
Khaiman Apr. 22 at 2:51 PM
$TOVX Takeover/Partnership Because TOVX now has "Phase 3 Ready" status and positive data in a hard-to-treat cancer niche a larger oncology player (like $MRK $BMY) looking to acquire them or sign a massive licensing deal
1 · Reply
taxplanr
taxplanr Apr. 22 at 1:36 PM
Tumors shrinking by 72% in six months with Ivermectin and Mebendazole $BNTX $MRNA $MRK $BMY https://makisw.substack.com/p/ivermectin-and-mebendazole-testimonial-0cb?utm_source=post-email-title&publication_id=1385328&post_id=194943878&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
2 · Reply
DragonAlgo
DragonAlgo Apr. 22 at 10:07 AM
🐉 $BMY CALL — DragonAlgo® Signal Contract: BMY CALL Expiry: 2026-04-24 | Strike: $59.00 | Type: CALL Option Plan (premium): Entry: $1.00 Stop: $0.72 TP1: $1.30 TP2: $1.70 TP3: $2.40 🔗 https://dragonalgo.com
0 · Reply
BigSweets
BigSweets Apr. 21 at 11:29 PM
$BMY I have 200 shares @45.66
0 · Reply
DragonAlgo
DragonAlgo Apr. 21 at 3:54 PM
🐉 $BMY PUT — DragonAlgo® Signal Contract: BMY PUT Expiry: 2026-04-24 | Strike: $59.00 | Type: PUT Option Plan (premium): Entry: $0.84 Stop: $0.60 TP1: $1.09 TP2: $1.43 TP3: $2.02 Rules-based execution profile. 🔗 https://dragonalgo.com
0 · Reply